×
Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder PDF
$ 40.00
Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder PDF quantity
$ 40.00
×
Successful Management of Difficult-to-Treat Aggression With Low-Dose Propranolol in a Patient With Intellectual Disability: A Case Report PDF
$ 40.00
Successful Management of Difficult-to-Treat Aggression With Low-Dose Propranolol in a Patient With Intellectual Disability: A Case Report PDF quantity
$ 40.00
×
Role of Mirtazapine in the Pharmacotherapy of Depression PDF
$ 40.00
Role of Mirtazapine in the Pharmacotherapy of Depression PDF quantity
$ 40.00
×
Cytochrome P450 2D6 Polymorphism and Its Impact on Decision-Making in Psychopharmacotherapy: Finding the Right Way in an Ultrarapid Metabolizing Patient PDF
$ 40.00
Cytochrome P450 2D6 Polymorphism and Its Impact on Decision-Making in Psychopharmacotherapy: Finding the Right Way in an Ultrarapid Metabolizing Patient PDF quantity
$ 40.00
×
First Reactions and Attitudes of Psychiatric Workers in Budapest Psychiatric Care Units Regarding the COVID-19 Pandemic PDF
$ 40.00
First Reactions and Attitudes of Psychiatric Workers in Budapest Psychiatric Care Units Regarding the COVID-19 Pandemic PDF quantity
$ 40.00
×
In the Mirror: Depression With Dysmorphia and Obsessive-Compulsive Disorder PDF
$ 40.00
In the Mirror: Depression With Dysmorphia and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA) PDF
$ 40.00
Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort Study: the Netherlands Study of Depression and Anxiety (NESDA) PDF quantity
$ 40.00
×
Paroxetine: Into Oblivion? PDF
$ 40.00
Paroxetine: Into Oblivion? PDF quantity
$ 40.00
×
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years PDF
$ 40.00
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart